CN101879257A - 一种治疗肿瘤的中药 - Google Patents
一种治疗肿瘤的中药 Download PDFInfo
- Publication number
- CN101879257A CN101879257A CN2009100836987A CN200910083698A CN101879257A CN 101879257 A CN101879257 A CN 101879257A CN 2009100836987 A CN2009100836987 A CN 2009100836987A CN 200910083698 A CN200910083698 A CN 200910083698A CN 101879257 A CN101879257 A CN 101879257A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- portions
- radix
- Prior art date
Links
- 239000003814 drugs Substances 0.000 title claims abstract description 28
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 26
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 11
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 11
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000004863 Frankincense Substances 0.000 claims abstract description 5
- 239000002994 raw materials Substances 0.000 claims abstract description 3
- 239000000843 powders Substances 0.000 claims description 17
- 239000002775 capsules Substances 0.000 claims description 16
- 241001312741 Gekko swinhonis Species 0.000 claims description 11
- 241001057584 Myrrha Species 0.000 claims description 11
- 239000000203 mixtures Substances 0.000 claims description 5
- 238000000034 methods Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 229940023488 Pill Drugs 0.000 claims description 2
- 239000008187 granular materials Substances 0.000 claims description 2
- 239000006187 pills Substances 0.000 claims description 2
- 238000002360 preparation methods Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 210000004369 Blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 229940079593 drugs Drugs 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001737 promoting Effects 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 229940116229 Borneol Drugs 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 240000001816 Prunella vulgaris Species 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 229930006709 borneol Natural products 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- 230000001502 supplementation Effects 0.000 abstract 1
- 210000003414 Extremities Anatomy 0.000 description 4
- 206010017758 Gastric cancer Diseases 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N Kairine Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000007502 Anemia Diseases 0.000 description 2
- 231100000614 Poisons Toxicity 0.000 description 2
- 230000003187 abdominal Effects 0.000 description 2
- 201000010099 diseases Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000003440 toxic substances Substances 0.000 description 2
- 206010000059 Abdominal discomfort Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003549 Asthenia Diseases 0.000 description 1
- 208000000409 Breast Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 206010008479 Chest pain Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010016256 Fatigue Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 210000000088 Lip Anatomy 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 210000004072 Lung Anatomy 0.000 description 1
- 206010025482 Malaise Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 240000004678 Panax pseudoginseng Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 210000003802 Sputum Anatomy 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 239000010419 fine particles Substances 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000002685 pulmonary Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 239000011901 water Substances 0.000 description 1
Abstract
一种治疗肿瘤的中药，属治疗肿瘤的中药领域；其目的是效果好、见效快；本发明采用半夏、半枝莲、当归、夏枯草、乳香、没药、白花蛇舌草、天龙、灵芝、冰片、三七、猫爪草等原料制成；它具有扶正培本，益气养血，活血化瘀，清热解毒抗癌的作用，效果好，见效快，具有效果显著，药效确切，见效较快的优点。
Description
一种治疗肿瘤的中药
技术领域
[0001] 本发明属于治疗肿瘤的中药领域。
背景技术
[0002] 在中药领域，目前用于治疗肿瘤的中药，存在几个方面不足：其一，效果不够明显， 其二，见效比较迟缓。大批肿瘤患者因药物不能有效抑制肿瘤生长、转移、扩散，影响了带瘤 生存的时间，患者及其家属很不满意。
[0003] 针对以上提出的问题，本发明提供一种治疗肿瘤的中药，它能解决以往此类中药 治疗中效果不够明显，见效比较迟缓的问题，效果好、见效快，具有效果显著，药效确切，见 效较快的优点。
发明内容
[0004]
[0005]
[0006]
[0007]
[0008]
[0009]
[0010] [0011]
本发明是通过以下技术方案来实现的：
1、一种治疗肿瘤的中药，采用中药原料制备，配方为（按重量比）
半夏2-
夏枯草3-
.18份 —22份 白花蛇舌草3——22份 冰片0. 2——1. 5份
半枝莲3-乳香1. 5-天龙1. 5-三七3—
-22份 -12份 -12份
当归5— 没药1. 5-灵芝5—
-22份 猫爪草3-
-30份 —12份 -30份 —22份
这种治疗肿瘤的中药是由下列方法制成的：
(1)按上述重量比，将半夏、半枝莲、当归、夏枯草、白花蛇舌草、猫爪草经常规水提 取工艺提取，制成浸膏细粉；
[0012] (2)按上述重量比，将乳香、没药、天龙、灵芝、冰片、三七分别研成细粉，与上述浸 膏细粉混合，搅拌均勻；根据需要，可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等 剂型。
[0013] 本发明是根据民间传统配方，根据中医扶正培本、活血化瘀的理论，精心研制而 成。方中灵芝、当归扶正培本、益气养血；乳香、没药、三七活血化瘀；半夏、猫爪草、天龙软 坚散结；半枝莲、夏枯草、白花蛇舌草清热解毒；冰片芳香开窍。诸药配伍，相得益彰，共奏 扶正培本，益气养血，活血化瘀，清热解毒抗癌之功，效果好，见效快，具有效果显著，药效确 切，见效较快的优点。
具体实施方式
[0014] 通过以下实施方式对本发明做具体说明：
[0015] 1、取以下配方（重量按克为单位）：
[0016] 半夏30克 半枝莲40克 当归60克
[0017] 夏枯草50克 乳香20克 没药20克
[0018] 白花蛇舌草50克天龙20克 灵芝50克[0019] 冰片3克 三七50克 猫爪草50克
[0020] 按规定重量，用常规水提取工艺将半夏、半枝莲、当归、夏枯草、白花蛇舌草、猫爪 草提取，制成浸膏细粉70克，将乳香、没药、天龙、灵芝、冰片、三七分别研成细粉，与上述浸 膏细粉混合，搅拌均勻，制成细小颗粒，装入0号胶囊，制成中药胶囊832粒，每粒胶囊内含 中药细粉及提取物0. 28克。
[0021] [0022]
[0023]
[0024]
[0025]
[0026] 克。
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]克。
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
2、取以下配方（重量按克为单位）： 半夏100克 半枝莲100克
夏枯草160克 乳香80克 白花蛇舌草150克天龙80克 冰片10克 三七130克
当归200克 没药80克 灵芝200克 猫爪草130克
按上述同样的方法，制成中药胶囊2821粒，每粒胶囊内含中药细粉及提取物0. 28
3、取以下配方（重量按克为单位）： 半夏180克 半枝莲2200克
夏枯草220克 乳香120克
白花蛇舌草220克 天龙120克 冰片15克 三七220克
当归300克 没药120克 灵芝300克 猫爪草220克
按上述同样的方法，制成中药胶囊4411粒，每粒胶囊内含中药细粉及提取物0. 28
4、取以下配方（按重量比）： 半夏3份 半枝莲3份
夏枯草4份 乳香3份 白花蛇舌草4份天龙2份 冰片0. 3份 三七4份
当归5份 没药2份 灵芝5份 猫爪草4份
按上述同样的方法，制成中药胶囊，每粒胶囊内含中药细粉及提取物0. 28克。 5、取以下配方（按重量比）：
当归30份 没药12份 灵芝30份 猫爪草20份
按上述同样的方法，制成中药胶囊，每粒胶囊内含中药细粉及提取物0. 28克。 临床资料：
本发明以中医胸部肿瘤为例，胃癌、肺癌、肝癌各占三分之一，经30例临床观察。 选择中医诊断胃癌、肺癌、肝癌为标准：肺癌——咳嗽不断，痰中带血，胸痛发闷，四肢无力， 肺部CT可见肿瘤；胃癌——腹部胀满，形体消瘦，疲惫无力，CT检查胃部有肿瘤；肝癌—— 体质虚弱，肢体无力，消化不良，恶心腹胀，贫血或有腹水、水肿、黄疸，CT检查可见肝部肿 瘤。如上症状，即可确诊。在确诊观察的对象中，男性16例，女性14例，无其它严重疾病， 年龄为41岁-73岁，平均年龄56. 3岁。 [0047] 疗效判定：
半夏18份 夏枯草20份 白花蛇舌草20份 冰片1. 5份
半枝莲20份 乳香12份 天龙12份 三七20份[0048] 1、显效：肺癌患者体质增强，身上有劲，咳嗽、胸闷等症状明显缓解；胃癌患者体 质增强，肢体有力，胀满、消化不良等胃部不适症状明显缓解；肝癌患者体质增强，肢体有 力，腹胀、贫血、消化不良等症状明显缓解；三种癌症CT检查均未见瘤体增大或者见肿瘤瘤 体缩小，其它部位未发现新生肿瘤。
[0049] 2、有效：体质增强，身上有劲，肿瘤瘤体增长不超过25 %，其它部位未发现新生肿 瘤病灶。
[0050] 3、无效：病症无变化，肿瘤瘤体增大超过25%，或者其它部位发现新生肿瘤病灶。
[0051] 临床实验时，停服其它药物和保健营养品。服用本发明中药胶囊，观察3个月，为 一个疗程。服用方法：每日3次，每次8粒胶囊，每粒胶囊内含中药细粉及提取物0.28克， 饭后温开水送服，1个月后症状即有缓解，服用3个月后，症状明显改善。临床实验的30人 中，显效17人，有效10人，无效3人，总有效率90 %。
Claims (1)
- 一种治疗肿瘤的中药，采用中药原料制备，配方为(按重量比)：半夏2——18份 半枝莲3——22份 当归5——30份夏枯草3——22份 乳香1.5——12份 没药1.5——12份白花蛇舌草3——22份 天龙1.5——12份 灵芝5——30份冰片0.2——1.5份 三七3——22份 猫爪草3——22份这种治疗肿瘤的中药是由下列方法制成的：(1)按上述重量比，将半夏、半枝莲、当归、夏枯草、白花蛇舌草、猫爪草经常规水提取工艺提取，制成浸膏细粉；(2)按上述重量比，将乳香、没药、天龙、灵芝、冰片、三七分别研成细粉，与上述浸膏细粉混合，搅拌均匀；根据需要，可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100836987A CN101879257A (zh) | 2009-05-08 | 2009-05-08 | 一种治疗肿瘤的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100836987A CN101879257A (zh) | 2009-05-08 | 2009-05-08 | 一种治疗肿瘤的中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101879257A true CN101879257A (zh) | 2010-11-10 |
Family
ID=43051486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100836987A CN101879257A (zh) | 2009-05-08 | 2009-05-08 | 一种治疗肿瘤的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101879257A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103356957A (zh) * | 2013-06-23 | 2013-10-23 | 金国栋 | 一种治疗胃癌的药物及其制备方法 |
| CN105477315A (zh) * | 2016-02-01 | 2016-04-13 | 张磊 | 一种治疗肿瘤的中药组合物 |
| CN106109821A (zh) * | 2016-06-29 | 2016-11-16 | 杨亚清 | 一种治疗癌症的中药组合物及其制备方法 |
| CN107961326A (zh) * | 2016-10-19 | 2018-04-27 | 南宁多灵生物科技有限公司 | 一种治疗肺癌的中药组合物 |
| CN108079257A (zh) * | 2018-01-23 | 2018-05-29 | 青岛大学附属医院 | 一种肿瘤临床治疗的药物组合及其制备方法 |
-
2009
- 2009-05-08 CN CN2009100836987A patent/CN101879257A/zh not_active Application Discontinuation
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103356957A (zh) * | 2013-06-23 | 2013-10-23 | 金国栋 | 一种治疗胃癌的药物及其制备方法 |
| CN105477315A (zh) * | 2016-02-01 | 2016-04-13 | 张磊 | 一种治疗肿瘤的中药组合物 |
| CN106109821A (zh) * | 2016-06-29 | 2016-11-16 | 杨亚清 | 一种治疗癌症的中药组合物及其制备方法 |
| CN107961326A (zh) * | 2016-10-19 | 2018-04-27 | 南宁多灵生物科技有限公司 | 一种治疗肺癌的中药组合物 |
| CN108079257A (zh) * | 2018-01-23 | 2018-05-29 | 青岛大学附属医院 | 一种肿瘤临床治疗的药物组合及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772745B (zh) | 一种治疗癌症的中药制剂及其制备方法 | |
| CN103041312B (zh) | 具有抗肿瘤作用的中药组合物及其制备方法和应用 | |
| CN101843787B (zh) | 一种治疗前列腺增生的中药 | |
| CN101843699B (zh) | 一种治疗前列腺增生的中药 | |
| CN100460008C (zh) | 治疗癌症的中药组合物 | |
| CN102178912B (zh) | 用于阳虚体质的人缓解胃脘冷痛症状的中药制剂及其制备方法和应用 | |
| CN101947304A (zh) | 一种治疗虚寒性胃肠病的中药组合物 | |
| CN101249235B (zh) | 治疗食道癌的中药及其制备方法 | |
| CN101843773B (zh) | 一种治疗肝硬化的中药 | |
| CN104352608B (zh) | 一种益气活血、软坚散结、解毒止痛的中药及其制备方法 | |
| CN103784802A (zh) | 一种治疗糖尿病的中药组合物 | |
| CN101773637A (zh) | 一种广谱抗病毒纳米中药及其生产方法 | |
| CN104491801A (zh) | 一种治疗急慢性胃炎的中药制剂及其制备方法 | |
| CN104288644A (zh) | 一种治疗脾虚的药物组合物及其制备方法 | |
| CN101972386A (zh) | 一种治疗糖尿病痛风的中药 | |
| CN101843694B (zh) | 一种治疗慢性肝炎的中药 | |
| CN102058865B (zh) | 一种治疗稳定期慢性阻塞性肺疾病的中药制剂 | |
| CN104491672A (zh) | 一种治疗慢性气管炎的中药制剂及其制备方法 | |
| CN104352793A (zh) | 一种治疗消化道出血的中药制剂及其制备方法 | |
| CN101658657B (zh) | 一种用于治疗慢性胆囊炎的药物 | |
| CN101537146B (zh) | 一种治疗结肠癌的中药 | |
| CN101530515B (zh) | 一种治疗糖尿病并发前列腺肿大的中药 | |
| CN102091225A (zh) | 一种治疗慢性前列腺炎的中药 | |
| CN102091268A (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
| CN102114074A (zh) | 一种治疗糖尿病性腹泻的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20101110 |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) |